249 related articles for article (PubMed ID: 28883275)
1. [Successful management of intraperitoneal bleeding with platelet apheresis and von Willebrand factor supplementation in a patient with essential thrombocythemia and acquired von Willebrand syndrome].
Ueki T; Takeshige K; Sumi M; Ueno M; Ichikawa N; Kobayashi H
Rinsho Ketsueki; 2017; 58(8):922-926. PubMed ID: 28883275
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation.
Oyedeji O; Sheqwara J; Onwubiko I; Lopez-Plaza I; Nagai S; Otrock ZK
Transfusion; 2021 Nov; 61(11):3277-3280. PubMed ID: 34569071
[TBL] [Abstract][Full Text] [Related]
3. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
[TBL] [Abstract][Full Text] [Related]
4. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
[TBL] [Abstract][Full Text] [Related]
5. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment.
Murakawa M; Okamura T; Tsutsumi K; Tanoguchi S; Kamura T; Shibuya T; Harada M; Niho Y
Acta Haematol; 1992; 87(1-2):83-7. PubMed ID: 1585777
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
8. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
Meskal A; Vertessen F; Van der Planken M; Berneman ZN
Ann Hematol; 1999 Sep; 78(9):426-30. PubMed ID: 10525831
[TBL] [Abstract][Full Text] [Related]
9. The course of acquired von Willebrand syndrome during pregnancy among patients with essential thrombocytosis.
Rottenstreich A; Kleinstern G; Amsalem H; Kalish Y
J Thromb Thrombolysis; 2018 Oct; 46(3):304-309. PubMed ID: 29654448
[TBL] [Abstract][Full Text] [Related]
10. The paradox of bleeding and thrombosis in thrombocythemia: is von Willebrand factor the link?
van Genderen PJ; Leenknegt H; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):385-9. PubMed ID: 9263356
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count.
Lancellotti S; Dragani A; Ranalli P; Petrucci G; Basso M; Tartaglione R; Rocca B; De Cristofaro R
J Thromb Haemost; 2015 Jul; 13(7):1226-37. PubMed ID: 25876231
[TBL] [Abstract][Full Text] [Related]
12. Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).
Rupa-Matysek J; Lewandowski K; Lewandowska M; Wojtasińska E; Wojtaszewska ML; Walczak M; Bykowska K; Komarnicki M
Int J Hematol; 2015 Apr; 101(4):405-10. PubMed ID: 25432436
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a rapid von Willebrand factor activity latex immuno assay for monitoring of patients with von Willebrand disease (VWD) receiving DDAVP or VWF replacement therapy.
Vinayagam S; Simons LR; Chowdary P; Thurlow P; Brooks SV; Riddell AF
Haemophilia; 2014 Jul; 20(4):e304-10. PubMed ID: 24758424
[TBL] [Abstract][Full Text] [Related]
14. Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus.
Niiya M; Niiya K; Takazawa Y; Hayashi Y; Tanio Y; Kushiro M; Tanimizu M; Hasegawa H; Tanimoto M
Blood Coagul Fibrinolysis; 2002 Jun; 13(4):361-5. PubMed ID: 12032403
[TBL] [Abstract][Full Text] [Related]
15. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
16. Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome.
Kogan L; Price R; Kotchetkov R
Front Oncol; 2024; 14():1326209. PubMed ID: 38361779
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
18. Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia.
Rolf N; Suttorp M; Budde U; Siegert G; Knoefler R
Thromb Haemost; 2010 Jun; 103(6):1272-4. PubMed ID: 20352170
[No Abstract] [Full Text] [Related]
19. [Acquired von Willebrand syndrome: a case series of nine patients and literature review].
Boissier E; Darnige L; Dougados J; Arlet JB; Dupeux S; Georgin-Lavialle S; Caron C; Tapon-Bretaudière J; Pouchot J; Ranque B
Rev Med Interne; 2014 Mar; 35(3):154-9. PubMed ID: 23746599
[TBL] [Abstract][Full Text] [Related]
20. [Acquired von Willebrand syndrome].
de Lange DW; Fijnheer R; Wittebol S
Ned Tijdschr Geneeskd; 2003 Sep; 147(37):1808-11. PubMed ID: 14526622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]